AI-generated price forecast for BioCryst Pharmaceuticals (BCRX) across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.
As of August 2026: K3vl4r's AI model currently reads BCRX as split 1/1 across its horizons (1 of 2 timeframes pointing up), with a last price of 9.70. Measured over its last 376 resolved daily forecasts (45-day window), the model's direction call on BCRX was correct 62% of the time. See our public, auditable track record →
Last price
9.70
AI outlook
split 1/1
Timeframes up
1 / 2
Measured daily accuracy
62%
376 resolved forecasts · 45d window
| Horizon | Direction | Projected move (end of horizon) | Bullish prob. |
|---|---|---|---|
| 1-hour | — | — | — |
| 4-hour~6 weeks out | — | — | — |
| Daily~4 months out | ▼ Down | -14.45% | 0% |
| Weekly~1.9 years out | ▲ Up | +15.18% | — |
From the market-news feed the forecasts are read against.
🔒
See the full BCRX forecast
Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.
Create a free account →Already have one? Log in
K3vl4r's AI model currently reads BCRX as split 1/1 — 1 of 2 forecast horizons point up, so the overall read is mixed. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.
Measured over its last 376 resolved daily forecasts (45-day window), the model's direction call on BCRX was correct 62% of the time. Measured over its last 28 resolved weekly forecasts (90-day window), the model's direction call on BCRX was correct 71% of the time. Accuracy is recomputed continuously against resolved outcomes and varies by symbol, horizon and market regime; past accuracy does not guarantee future results. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.
K3vl4r's model projects BCRX toward $9.69 over the next ~4 months, a -0.1% move from $9.70. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.
Over its longest horizon (~~1.9 years), the model's projected target for BCRX is $9.93 (+0.2% vs $9.91). Confidence decreases the further out the horizon, so treat longer-range targets as one scenario, not a guarantee. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.
Part of Biotech & Pharma forecasts — browse the full sector.
Or see the full BCRX price prediction (2027–2040), or the forecast for today, tomorrow and this week.
Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.
K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.
Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.